A large trial showed that the weight-loss drug could reduce liver inflammation and scarring caused by a common condition.

Wegovy (semaglutide) could offer a new option to treat severe liver disease based on new clinical trial evidence. The GLP-1 ...

Prior to starting the trial, the participants also had moderate to high levels of scar tissue in the liver, known as stage 2 ...

The active ingredient in the popular weight loss drug Wegovy may help treat a type of fatty liver disease, according to a new ...

Drugs made to treat diabetes and weight loss could stop or even reverse a severe liver disease, according to a new study. The ...

A late-stage clinical study showed that this weight loss drug helped 2 out of 3 people with the life-threatening liver ...

A popular drug for treating obesity and diabetes is now showing benefits in fighting a deadly liver disease. Semaglutide, marketed under names including Ozempic and Wegovy, aids weight loss and ...

A large trial showed that the weight-loss drug could reduce liver inflammation and scarring caused by the common condition ...

A global trial finds Wegovy and Ozempic significantly improve liver health in patients and treats those with advanced fatty ...

Nearly twice as many people taking semaglutide stopped their fatty liver disease without further scarring of the organ, ...

GLP-1 RA helped resolution of steatohepatitis without worsening fibrosis and reduced liver fibrosis without worsening steatohepatitis.